4.6 Article

Genome-Wide Association Study Using Extreme Truncate Selection Identifies Novel Genes Affecting Bone Mineral Density and Fracture Risk

Journal

PLOS GENETICS
Volume 7, Issue 4, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pgen.1001372

Keywords

-

Funding

  1. National Health and Medical Research Council (Australia) [511132, 569807]
  2. Australian Cancer Research Foundation
  3. Rebecca Cooper Foundation (Australia)
  4. National Health and Medical Research Council (Australia)
  5. Medical Research Council [MRC G0800582, G0600702]
  6. Wellcome Trust [WT083431MA]
  7. Health Research Council of New Zealand
  8. Sanofi-Aventis
  9. Eli Lilly
  10. Novartis
  11. Pfizer
  12. Proctor
  13. Gamble Pharmaceuticals
  14. Roche
  15. Medical Research Council (UK) [MRC G0600702]
  16. Netherlands Organisation of Scientific Research NWO [175.010.2005.011, 911-03-012]
  17. Research Institute for Diseases in the Elderly (RIDE2) [014-93-015]
  18. Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]
  19. Erasmus Medical Center
  20. Erasmus University, Rotterdam
  21. Netherlands Organization for the Health Research and Development (ZonMw)
  22. Research Institute for Diseases in the Elderly (RIDE)
  23. Ministry of Education, Culture, and Science
  24. Ministry for Health, Welfare and Sports
  25. European Commission
  26. Municipality of Rotterdam
  27. German Bundesministerium fuer Forschung und Technology [01 AK 803 A-H, 01 IG 07015 G]
  28. National Health and Medical Research Council, Australia
  29. Australian National Health and Medical Research Council
  30. MBF Living Well foundation
  31. Ernst Heine Family Foundation
  32. Amgen
  33. Eli Lilly International
  34. GE-Lunar
  35. Merck Australia
  36. Sanofi-Aventis Australia
  37. Servier
  38. Healthway Health Promotion Foundation of Western Australia
  39. Australasian Menopause Society
  40. National Health and Medical Research Council
  41. Medical research Council UK
  42. Arthritis Research UK
  43. Canadian Institutes of Health Research
  44. Canadian Foundation for Innovation
  45. Fonds de la Recherche en Sante Quebec
  46. Lady Davis Institute
  47. Ministere du Developpemente conomique
  48. innovation et exportation du Quebec
  49. Chronic Disease Research Foundation
  50. European Society for Clinical and Economic aspects of Osteoporosis
  51. European Union
  52. National Institute for Health Research
  53. Victorian Health Promotion Foundation
  54. Geelong Region Medical Research Foundation
  55. National Health and Medical Research Council, Australia [628582]
  56. Action Research UK
  57. MRC [G0600702, G1000467, MC_U142684172, MC_U142684175, G0600705, G9825289, MC_U142661184, G0800582] Funding Source: UKRI
  58. Medical Research Council [G1000467, U1475000001, MC_U142684175, MC_U142684172, G0800582, G0600705, G9825289, G0600702, MC_UP_A620_1014, MC_U142661184] Funding Source: researchfish
  59. National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish
  60. Versus Arthritis [17489] Funding Source: researchfish

Ask authors/readers for more resources

Osteoporotic fracture is a major cause of morbidity and mortality worldwide. Low bone mineral density (BMD) is a major predisposing factor to fracture and is known to be highly heritable. Site-, gender-, and age- specific genetic effects on BMD are thought to be significant, but have largely not been considered in the design of genome-wide association studies (GWAS) of BMD to date. We report here a GWAS using a novel study design focusing on women of a specific age (postmenopausal women, age 55-85 years), with either extreme high or low hip BMD (age- and gender- adjusted BMD zscores of +1.5 to +4.0, n = 1055, or -4.0 to -1.5, n = 900), with replication in cohorts of women drawn from the general population (n = 20,898). The study replicates 21 of 26 known BMD-associated genes. Additionally, we report suggestive association of a further six new genetic associations in or around the genes CLCN7, GALNT3, IBSP, LTBP3, RSPO3, and SOX4, with replication in two independent datasets. A novel mouse model with a loss-of-function mutation in GALNT3 is also reported, which has high bone mass, supporting the involvement of this gene in BMD determination. In addition to identifying further genes associated with BMD, this study confirms the efficiency of extreme-truncate selection designs for quantitative trait association studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available